Medicine Man Financials
| SHWZ Stock | USD 0.11 0.13 54.17% |
Medicine |
Understanding current and past Medicine Man Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Medicine Man's financial statements are interrelated, with each one affecting the others. For example, an increase in Medicine Man's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Medicine Man's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Medicine Man Technologies. Check Medicine Man's Beneish M Score to see the likelihood of Medicine Man's management manipulating its earnings.
Medicine Man Stock Summary
Medicine Man Technologies, Inc., doing business as Schwazze, operates as a cannabis company. The company was incorporated in 2014 and is headquartered in Denver, Colorado. Medicine Man operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 389 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US58468U1060 |
| Business Address | 4880 Havana Street, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.schwazze.com |
| Phone | 303 371 0387 |
| Currency | USD - US Dollar |
Medicine Man Key Financial Ratios
Medicine Man's financial ratios allow both analysts and investors to convert raw data from Medicine Man's financial statements into concise, actionable information that can be used to evaluate the performance of Medicine Man over time and compare it to other companies across industries.| Return On Equity | 0.16 | |||
| Return On Asset | 0.0452 | |||
| Target Price | 2.23 | |||
| Number Of Employees | 389 | |||
| Beta | 1.92 |
Medicine Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medicine Man's current stock value. Our valuation model uses many indicators to compare Medicine Man value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medicine Man competition to find correlations between indicators driving Medicine Man's intrinsic value. More Info.Medicine Man Technologies is rated second in return on equity category among its peers. It is currently regarded as top stock in return on asset category among its peers reporting about 0.29 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Medicine Man Technologies is roughly 3.47 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Medicine Man by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Medicine Man's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Medicine Man Technologies Systematic Risk
Medicine Man's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Medicine Man volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Medicine Man Technologies correlated with the market. If Beta is less than 0 Medicine Man generally moves in the opposite direction as compared to the market. If Medicine Man Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Medicine Man Technologies is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Medicine Man is generally in the same direction as the market. If Beta > 1 Medicine Man moves generally in the same direction as, but more than the movement of the benchmark.
Medicine Man November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Medicine Man help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Medicine Man Technologies. We use our internally-developed statistical techniques to arrive at the intrinsic value of Medicine Man Technologies based on widely used predictive technical indicators. In general, we focus on analyzing Medicine Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Medicine Man's daily price indicators and compare them against related drivers.
| Downside Deviation | 44.69 | |||
| Information Ratio | 0.1526 | |||
| Maximum Drawdown | 236.06 | |||
| Value At Risk | (50.00) | |||
| Potential Upside | 100.0 |
Additional Tools for Medicine Pink Sheet Analysis
When running Medicine Man's price analysis, check to measure Medicine Man's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicine Man is operating at the current time. Most of Medicine Man's value examination focuses on studying past and present price action to predict the probability of Medicine Man's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicine Man's price. Additionally, you may evaluate how the addition of Medicine Man to your portfolios can decrease your overall portfolio volatility.